1.49
price down icon4.49%   -0.07
after-market Dopo l'orario di chiusura: 1.48 -0.01 -0.67%
loading

Zentalis Pharmaceuticals Inc Azioni (ZNTL) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- 26.86 - -
Operating Expenses
20.97%
36.06
45.62 76.71 51.43 65.15
Operating Income/Loss
20.97%
-36.06
-45.62 -49.85 -51.43 -65.15
Income/Loss From Continuing Operations Before Tax
44.34%
-26.87
-48.28 -47.68 -40.19 -88.01
Income Tax Expense/Benefit
-
- -0.205 -0.027 0.266
Income/Loss From Continuing Operations After Tax
44.34%
-26.87
-48.28 -47.47 -40.16 -88.28
Net Income/Loss
44.34%
-26.87
-48.28 -47.47 -40.16 -88.28
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.44%
71.99
71.68 0.063 71.11 71.04
Diluted Average Shares
0.44%
71.99
71.68 0.063 71.11 71.04
Basic Earnings Per Share
44.78%
-0.37
-0.67 -0.66 -0.56 -1.24
Diluted Earnings Per Share
44.78%
-0.37
-0.67 -0.66 -0.56 -1.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):